Amryt Pharma Holdings Ltd
LSE:AMYT
Income Statement
Earnings Waterfall
Amryt Pharma Holdings Ltd
Revenue
|
210.2m
USD
|
Cost of Revenue
|
-106.8m
USD
|
Gross Profit
|
103.4m
USD
|
Operating Expenses
|
-126.8m
USD
|
Operating Income
|
-23.3m
USD
|
Other Expenses
|
-64.2m
USD
|
Net Income
|
-87.5m
USD
|
Income Statement
Amryt Pharma Holdings Ltd
Mar-2009 | Sep-2009 | Mar-2010 | Sep-2010 | Mar-2011 | Sep-2011 | Mar-2012 | Sep-2012 | Mar-2013 | Sep-2013 | Mar-2014 | Sep-2014 | Mar-2015 | Sep-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
2
N/A
|
2
+6%
|
2
-4%
|
2
-37%
|
1
-43%
|
1
-12%
|
(0)
N/A
|
(0)
-660%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+744%
|
7
+446%
|
14
+85%
|
15
+13%
|
17
+8%
|
18
+8%
|
58
+227%
|
103
+77%
|
140
+36%
|
189
+35%
|
183
-3%
|
186
+2%
|
203
+9%
|
210
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
(6)
|
(6)
|
(6)
|
(7)
|
(42)
|
(75)
|
(100)
|
(128)
|
(119)
|
(110)
|
(107)
|
(107)
|
|
Gross Profit |
1
N/A
|
1
+25%
|
1
-17%
|
1
-39%
|
0
-41%
|
0
-28%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+1 000%
|
4
+467%
|
8
+80%
|
9
+15%
|
10
+16%
|
11
+6%
|
16
+45%
|
28
+74%
|
39
+40%
|
61
+57%
|
64
+3%
|
77
+20%
|
96
+26%
|
103
+7%
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(3)
|
(7)
|
(14)
|
(23)
|
(26)
|
(28)
|
(31)
|
(52)
|
(80)
|
(93)
|
(119)
|
(109)
|
(109)
|
(113)
|
(127)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(4)
|
(7)
|
(12)
|
(15)
|
(18)
|
(20)
|
(36)
|
(55)
|
(68)
|
(86)
|
(81)
|
(82)
|
(83)
|
(93)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(7)
|
(11)
|
(11)
|
(10)
|
(11)
|
(16)
|
(25)
|
(26)
|
(33)
|
(28)
|
(28)
|
(30)
|
(34)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(1)
-178%
|
(1)
-58%
|
(1)
-5%
|
(0)
+80%
|
(0)
-129%
|
(1)
-269%
|
(2)
-19%
|
(2)
-27%
|
(3)
-19%
|
(3)
-2%
|
(2)
+7%
|
(3)
-32%
|
(6)
-81%
|
(9)
-62%
|
(15)
-61%
|
(17)
-10%
|
(17)
-4%
|
(20)
-15%
|
(36)
-80%
|
(52)
-45%
|
(54)
-4%
|
(58)
-6%
|
(45)
+21%
|
(33)
+28%
|
(17)
+49%
|
(23)
-40%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(14)
|
(17)
|
(19)
|
(20)
|
(18)
|
(19)
|
(24)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(31)
|
(31)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
(3)
|
(18)
|
(19)
|
(16)
|
(16)
|
(1)
|
(0)
|
(0)
|
(11)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(8)
|
(12)
|
(8)
|
(10)
|
(9)
|
(8)
|
(13)
|
(13)
|
(17)
|
(40)
|
(40)
|
(40)
|
(42)
|
|
Pre-Tax Income |
(0)
N/A
|
(0)
+89%
|
(0)
-440%
|
(1)
-119%
|
(1)
-51%
|
(1)
-10%
|
(0)
+85%
|
(2)
-900%
|
(2)
-12%
|
(1)
+69%
|
(2)
-265%
|
(2)
-29%
|
(33)
-1 258%
|
(34)
0%
|
(5)
+84%
|
(8)
-44%
|
(18)
-125%
|
(28)
-58%
|
(27)
+4%
|
(29)
-11%
|
(34)
-17%
|
(67)
-94%
|
(97)
-46%
|
(101)
-4%
|
(110)
-9%
|
(106)
+4%
|
(91)
+14%
|
(76)
+16%
|
(100)
-32%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
1
|
3
|
6
|
4
|
1
|
(1)
|
(4)
|
13
|
|
Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(33)
|
(34)
|
(5)
|
(8)
|
(18)
|
(28)
|
(27)
|
(30)
|
(34)
|
(65)
|
(94)
|
(95)
|
(105)
|
(105)
|
(92)
|
(81)
|
(88)
|
|
Net Income (Common) |
(0)
N/A
|
(0)
+93%
|
(0)
-800%
|
(0)
+37%
|
0
N/A
|
(0)
N/A
|
(1)
-187%
|
(2)
-241%
|
(2)
+25%
|
(1)
+69%
|
(2)
-265%
|
(2)
-29%
|
(33)
-1 258%
|
(34)
0%
|
(5)
+84%
|
(8)
-44%
|
(18)
-125%
|
(28)
-58%
|
(27)
+4%
|
(30)
-11%
|
(34)
-17%
|
(65)
-90%
|
(94)
-44%
|
(95)
0%
|
(105)
-11%
|
(105)
+1%
|
(92)
+12%
|
(81)
+12%
|
(88)
-8%
|
|
EPS (Diluted) |
-0.92
N/A
|
-0.06
+93%
|
-0.53
-783%
|
-0.33
+38%
|
0.08
N/A
|
-0.45
N/A
|
-1.29
-187%
|
-0.76
+41%
|
-0.33
+57%
|
-0.09
+73%
|
-0.29
-222%
|
-0.34
-17%
|
-4.64
-1 265%
|
-4.66
0%
|
-0.28
+94%
|
-0.22
+21%
|
-0.5
-127%
|
-0.7
-40%
|
-0.58
+17%
|
-0.64
-10%
|
-0.75
-17%
|
-0.62
+17%
|
-0.61
+2%
|
-0.61
N/A
|
-0.67
-10%
|
-0.63
+6%
|
-0.52
+17%
|
-0.45
+13%
|
-0.33
+27%
|